Uncategorized - April 2, 2015
New Heart Blood Clot Option
A study by the Cardiology Department of Copenhagen University Hospital, Rigshospitalet, demonstrated how to improve the treatment of patients suffering from blood clots in the heart (coronary thrombosis) so that the risk of death, having a new thrombosis or needing renewed angioplasty can be reduced by 44 percent, according to an article in ScienceNordic. The […]
Intellectual Property - April 2, 2015
Patent for Nail Fungus Drug
The European Patent Office has issued a patent for Moberg PharmaAB’s topical treatment MOB-015 for onychomycosis (toenail fungus). The patent is expected to be in effect until 2032. Moberg Pharma reported positive results last September from a Phase II study of MOB-015 and in January 2015, received similar patent approval in the U.S. “The granted […]
Pharma Business - April 2, 2015
Biosimilar Drug a Hit in Norway
A biosimilar of Merck’s popular arthritis drug Remicade is going for a discount of nearly 70 percent of the branded price in Norway, upsetting conventional wisdom and competitors, according to a FiercePharma article. Finnish drug company Orion Oyj, which licenses the biosimilar Remsima from South Korea’s Celltrion, began with a 39 percent discount for the […]
In a new job - April 2, 2015
New CEO for Merivaara Corp.
Markku Aherto has been appointed the new CEO of Finland’s Merivaara Corporation, according to a company statement. Aherto has been working as sales director of the company since January of this year. Prior to that, he served in the Board of OscareMedical Oy. Between 2005 and 2011, Aherto also was at Merivaara, as director of […]
Uncategorized - April 2, 2015
Concerns About Tots’ Poor Sleep
Researchers at the Norwegian University of Science and Technology (NTNU)’s Department of Psychology have found that serious sleep disorders in toddlers can have long-term consequences. About 1,000 toddlers were interviewed for the study, which showed that 4-year-olds with sleep disorders have a higher risk of developing symptoms of psychiatric problems as 6-year-olds, compared with children […]
Uncategorized - April 2, 2015
Chemo Hits Cancer Stem Cells
Researchers at the University of Bergen have conducted successful trials of a new type of chemotherapy that short-circuits cancer stem cells’ signaling system, the “command center” for the creation of new cancer cells. “In both laboratory and animal testing the drugs have shown tumors to stop growing, to be reduced or even to disappear,” said […]
